CRISPR-Modified Skin Grafts to Treat Addiction? ‘The Opportunities Are Endless,’ Says CEO
AddGraft has developed a platform that uses skin epidermal progenitor cells to deliver one or more therapeutic agents. (Image: iStock.com/Floaria Bicher) AddGraft Therapeutics has developed a novel platform that aims to effectively treat substance use disorders with genetically engineered skin… Keep reading